XML 47 R37.htm IDEA: XBRL DOCUMENT v3.21.2
Acquisitions - Additional Information (Detail) - USD ($)
9 Months Ended
Sep. 20, 2021
Sep. 16, 2021
Jun. 22, 2021
Oct. 27, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Business Acquisition [Line Items]              
Payments to Acquire Businesses, Net of Cash Acquired         $ 120,979,000 $ 28,445,000  
Goodwill         833,559,000   $ 618,305,000
Selling, general and administrative              
Business Acquisition [Line Items]              
Transaction costs         $ 3,400,000   4,000,000.0
Avitide, Inc.              
Business Acquisition [Line Items]              
Cash consideration $ 150,000,000.0 $ 75,000,000.0          
Shares issued for business acquisition   271,096     271,096    
Value of common stock issued   $ 77,600,000     $ 77,576,000    
Net liabilities assumed   5,200,000          
Business combination, consideration transferred         232,542,000    
Fair value of acquired finite lived intangible assets   44,300,000          
Goodwill         193,463,000    
Intangible Asset Residual Value   193,500,000          
Transaction costs         600,000    
Business combination contingent consideration   80,000,000.0     79,962,000    
Avitide, Inc. | Capital Stock              
Business Acquisition [Line Items]              
Cash consideration   150,000,000.0          
Payments to Acquire Businesses, Net of Cash Acquired   149,400,000          
Business combination, consideration transferred   275,000,000.0          
Business acquisition, Indemnification escrow   800,000          
Business combination contingent consideration   $ 125,000,000.0          
Polymem S.A.              
Business Acquisition [Line Items]              
Cash consideration     $ 47,000,000.0        
Net liabilities assumed         2,200,000    
Fair value of acquired finite lived intangible assets         25,700    
Goodwill         23,453,000    
Intangible Asset Residual Value         23,500,000    
Transaction costs         1,900,000    
Business acquisition, Indemnification escrow         4,300,000    
ARTeSYN Biosolutions              
Business Acquisition [Line Items]              
Cash consideration       $ 130,000 $ 130,700,000    
Shares issued for business acquisition         372,990    
Value of common stock issued       70,000,000 $ 69,422,000    
Working capital adjustment         100,000    
Business combination, consideration transferred       200,000,000 203,993,000    
Fair value of tangible assets acquired         8,000,000.0    
Fair value of acquired finite lived intangible assets         67,400,000    
Goodwill         128,598,000    
Intangible Asset Residual Value         128,600,000    
Business combination contingent consideration       $ 1,500,000 1,548,000    
Business combination settlement of preexisting invoices         2,310,000    
ARTeSYN Biosolutions | Goodwill [Member]              
Business Acquisition [Line Items]              
Intangible Asset Residual Value         128,600    
Non Metallic Solutions              
Business Acquisition [Line Items]              
Working capital adjustment         100,000    
Business combination, consideration transferred         16,100,000    
Fair value of tangible assets acquired         900,000    
Fair value of acquired finite lived intangible assets         8,500,000    
Goodwill         6,713,000    
Intangible Asset Residual Value         6,700,000    
Transaction costs         400,000   $ 200,000
Business combinations cash deposited in escrow account         $ 1,300,000